No sense in ignoring it . . .

1,260 Views | 5 Replies | Last: 1 yr ago by UgaBoz53
Nostradawgus
How long do you want to ignore this user?
That was a bad loss last night. We're on a stretch of bad losses. Not sure I now see another regular season win on the schedule.

Is there anything White can do to stop the hemorrhage? Yeah, we could have used Roberts, but we didn't lose that game because of Roberts.
Monkdawg
How long do you want to ignore this user?
We aren't winning many games with Roberts out. As erratic as he can be sometimes, he is still our "best" player. Lindsay leaving took away much of our inside depth and losing Roberts really hurts us on both ends of the floor.
Microwave
How long do you want to ignore this user?
We've got a good shot against LSU and South Carolina. We could also sneak one in against one of our more successful opponents - wouldn't it be nice to gig the Gators!!

Here's hoping.
SidViciousDawg
How long do you want to ignore this user?
Yep we could win 1-3 more but you can't ignore that we've lost 6 of our last 7 and the lone win was in overtime at home against a 1-10 South Carolina. LSU is on a 10 game losing streak, yep we could win that one. After the 3-1 start people got a little hopeful thinking we might deserve some Top 25 votes, we were not good then and we're not good now.

White's a good coach and a better person, glad to have him here, he'll get us to respectability.
UgaBoz53
How long do you want to ignore this user?
we might get beat by 25 saturday
ATLSTNMTN53DAWG
UgaBoz53
How long do you want to ignore this user?
Monkdawg said:

We aren't winning many games with Roberts out. As erratic as he can be sometimes, he is still our "best" player. Lindsay leaving took away much of our inside depth and losing Roberts really hurts us on both ends of the floor.
yep, great point
is he in the dawg house with white?
he went into a slump and now has a concussion
ATLSTNMTN53DAWG
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.